The disorders which are screened for may otherwise not be detected before developmental disability or death occurs. Newborns with these disorders typically appear normal at birth.
Early detection, diagnosis, and treatment of certain genetic, endocrine, or metabolic disorders can lead to significant reductions of death, disease, and associated disabilities. Therefore, newborn screening is recognised internationally as an essential, preventive health program for early identification of these disorders. This type of program has an impact not only on the health and wellbeing of babies, but also on their families and the community they live in.
Every newborn has the right to have a newborn screening test done.
Early diagnosis and treatment ensure optimal living, allowing an individual to contribute to society and not become a long-term social burden.
FirstScreen offers a full management service to both doctors and patients, from the time a patient signs up for NBS until the results are issued to the paediatrician by: